 vivo biologic effect interleukin alfa natural immunity patients head neck cancer association deficient natural immunity risk metastatic disease ability natural killer cell function therapeutic significance effect continuous infusion interleukin intramuscular interferon alfa natural immune status patients head neck cancer effect interleukin alfa therapy lymphokine-activated killer cell activity total lymphocyte count percent lymphocyte subsets levels immune complexes antibody classes percent absolute number natural killer cells ie lymphocytes peripheral blood natural killer cell activity targets treatment immune parameters demonstrated capacity natural immune function potential use interleukin regimens preventive measure metastatic disease patients head neck cancer